NCT01855412

Observational Study to Evaluate PAD Treatment Clinical and Economic Outcomes

LIBERTY 360: Prospective, Observational, Multi-Center Clinical Study to Evaluate Acute and Long Term Clinical and Economic Outcomes of Endovascular Device Intervention in Patients With Distal Outflow Peripheral Arterial Disease (PAD)

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 1,204 (actual)
• Sponsor: Abbott Medical Devices · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate acute and long term clinical and economic outcomes of endovascular procedures to treat Peripheral Arterial Disease (PAD).

Detailed description

This is a prospective, observational, multi-center, clinical study examining predictors of clinical outcomes for patients undergoing endovascular treatment of lesions within or extending into the target area (10 cm above the medial epicondyle to the digital arteries). This includes disease in a vessel located within or extending into the distal superficial femoral artery (SFA), popliteal (POP), tibial peroneal trunk (TPT), anterior tibial (AT), posterior tibial (PT), and peroneal tibial (PR) arteries.

Conditions

• Peripheral Arterial Occlusive Disease

Interventions

Type	Name	Description
OTHER	PAD endovascular treatments	All FDA-cleared endovascular PAD treatments

Timeline

• Start date: 2013-05-01
• Primary completion: 2019-04-11
• Completion: 2019-04-11
• First posted: 2013-05-16
• Last updated: 2023-07-18
• Results posted: 2021-05-18

Locations

52 sites across 1 country: United States